IL156664A0 - Tacrolimus derivatives and pharmaceutical compositions containing the same - Google Patents
Tacrolimus derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL156664A0 IL156664A0 IL15666401A IL15666401A IL156664A0 IL 156664 A0 IL156664 A0 IL 156664A0 IL 15666401 A IL15666401 A IL 15666401A IL 15666401 A IL15666401 A IL 15666401A IL 156664 A0 IL156664 A0 IL 156664A0
- Authority
- IL
- Israel
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- tacrolimus derivatives
- tacrolimus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25850000P | 2000-12-29 | 2000-12-29 | |
| PCT/US2001/050419 WO2002053159A1 (en) | 2000-12-29 | 2001-12-31 | Neurotrophic tacrolimus analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL156664A0 true IL156664A0 (en) | 2004-01-04 |
Family
ID=22980816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15666401A IL156664A0 (en) | 2000-12-29 | 2001-12-31 | Tacrolimus derivatives and pharmaceutical compositions containing the same |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1353671A4 (pt) |
| JP (1) | JP2004527472A (pt) |
| KR (2) | KR100794204B1 (pt) |
| CN (1) | CN1293877C (pt) |
| AR (1) | AR035411A1 (pt) |
| AU (1) | AU2002231277B2 (pt) |
| BR (1) | BR0116762A (pt) |
| CA (1) | CA2433384A1 (pt) |
| CZ (1) | CZ20032060A3 (pt) |
| HU (1) | HUP0302521A3 (pt) |
| IL (1) | IL156664A0 (pt) |
| MX (1) | MXPA03005941A (pt) |
| NO (1) | NO20032913D0 (pt) |
| NZ (1) | NZ527209A (pt) |
| PL (1) | PL366301A1 (pt) |
| RU (1) | RU2288716C2 (pt) |
| WO (1) | WO2002053159A1 (pt) |
| ZA (1) | ZA200305806B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901023A0 (en) * | 2003-03-04 | 2003-03-20 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| EP1706117A1 (en) * | 2004-01-20 | 2006-10-04 | Astellas Pharma Inc. | Method for treating erectile dysfunction |
| EP1810675A1 (en) * | 2006-01-18 | 2007-07-25 | Institut Curie | Method for treating Huntington's disease by inhibiting dephosphorylation of huntingtin at S421 |
| JP2009102226A (ja) * | 2006-02-14 | 2009-05-14 | Meiji Milk Prod Co Ltd | 脊髄損傷治療剤 |
| BRPI0916232A2 (pt) * | 2008-07-23 | 2017-08-29 | Novartis Ag | Moduladores do receptor de esfingosina-1-fosfato e seu uso para tratar inflamação muscular |
| WO2013124416A1 (en) * | 2012-02-23 | 2013-08-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Calcineurin inhibitors for use in the treatment of lesional vestibular disorders |
| GB201309375D0 (en) * | 2013-05-24 | 2013-07-10 | Chronos Therapeutics Ltd | Medical methods and compounds for medical use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU630866B2 (en) * | 1987-12-09 | 1992-11-12 | Fisons Plc | Macrocyclic compounds |
| GR1001225B (el) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους. |
| US5541193A (en) * | 1991-09-05 | 1996-07-30 | Abbott Laboratories | Heterocycle-containing macrocyclic immunomodulators |
| GB9202196D0 (en) * | 1992-02-01 | 1992-03-18 | Fisons Plc | Method of treatment |
| GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
| GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
-
2001
- 2001-12-27 AR ARP010106058A patent/AR035411A1/es unknown
- 2001-12-31 IL IL15666401A patent/IL156664A0/xx unknown
- 2001-12-31 CN CNB018228860A patent/CN1293877C/zh not_active Expired - Fee Related
- 2001-12-31 RU RU2003123493/15A patent/RU2288716C2/ru not_active IP Right Cessation
- 2001-12-31 WO PCT/US2001/050419 patent/WO2002053159A1/en active IP Right Grant
- 2001-12-31 BR BR0116762-6A patent/BR0116762A/pt not_active Application Discontinuation
- 2001-12-31 KR KR1020037008787A patent/KR100794204B1/ko not_active IP Right Cessation
- 2001-12-31 KR KR1020077003889A patent/KR20070030331A/ko not_active Application Discontinuation
- 2001-12-31 PL PL01366301A patent/PL366301A1/xx not_active Application Discontinuation
- 2001-12-31 MX MXPA03005941A patent/MXPA03005941A/es active IP Right Grant
- 2001-12-31 NZ NZ527209A patent/NZ527209A/en unknown
- 2001-12-31 CZ CZ20032060A patent/CZ20032060A3/cs unknown
- 2001-12-31 HU HU0302521A patent/HUP0302521A3/hu unknown
- 2001-12-31 CA CA002433384A patent/CA2433384A1/en not_active Abandoned
- 2001-12-31 JP JP2002554109A patent/JP2004527472A/ja not_active Ceased
- 2001-12-31 AU AU2002231277A patent/AU2002231277B2/en not_active Ceased
- 2001-12-31 EP EP01991558A patent/EP1353671A4/en not_active Withdrawn
-
2003
- 2003-06-24 NO NO20032913A patent/NO20032913D0/no not_active Application Discontinuation
- 2003-07-28 ZA ZA2003/05806A patent/ZA200305806B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20032913D0 (no) | 2003-06-24 |
| EP1353671A1 (en) | 2003-10-22 |
| HUP0302521A3 (en) | 2007-03-28 |
| PL366301A1 (en) | 2005-01-24 |
| CA2433384A1 (en) | 2002-07-11 |
| RU2003123493A (ru) | 2005-01-20 |
| CN1293877C (zh) | 2007-01-10 |
| ZA200305806B (en) | 2005-01-26 |
| BR0116762A (pt) | 2004-08-10 |
| EP1353671A4 (en) | 2004-07-14 |
| HUP0302521A2 (hu) | 2003-11-28 |
| KR100794204B1 (ko) | 2008-01-14 |
| KR20070030331A (ko) | 2007-03-15 |
| MXPA03005941A (es) | 2005-02-14 |
| JP2004527472A (ja) | 2004-09-09 |
| WO2002053159A1 (en) | 2002-07-11 |
| AU2002231277B2 (en) | 2006-11-30 |
| NZ527209A (en) | 2005-09-30 |
| CZ20032060A3 (cs) | 2004-01-14 |
| AR035411A1 (es) | 2004-05-26 |
| CN1538843A (zh) | 2004-10-20 |
| KR20040007431A (ko) | 2004-01-24 |
| RU2288716C2 (ru) | 2006-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
| HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
| IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
| IL150734A0 (en) | Azaindole derivatives and pharmaceutical compositions containing the same | |
| IL156354A0 (en) | Pyridoindole derivatives and pharmaceutical compositions containing the same | |
| IL161616A0 (en) | Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| IL151829A0 (en) | Carbamate derivatives and pharmaceutical compositions containing the same | |
| AU2001290257A2 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
| AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
| IL152490A0 (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
| IL158044A0 (en) | Cyclopropylindole derivatives and pharmaceutical compositions containing the same | |
| IL158300A0 (en) | Bisarylimidazol derivatives and pharmaceutical compositions containing the same | |
| IL151952A0 (en) | Aminopyridine derivatives and pharmaceutical compositions containing the same | |
| IL152718A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
| IL177018A0 (en) | Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same | |
| IL156389A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL154786A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL145757A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL145756A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL156812A0 (en) | Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same | |
| IL152094A0 (en) | Ecteinascidin derivatives and pharmaceutical compositions containing the same | |
| IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
| IL150905A0 (en) | Andrographolide derivatives and pharmaceutical compositions containing the same | |
| IL154850A0 (en) | Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of name of proprietor(s) |